Century Therapeutics (IPSC) Change in Cash (2020 - 2026)

Century Therapeutics (IPSC) has 7 years of Change in Cash data on file, last reported at -$11.3 million in Q1 2026.

• Change in Cash for Q1 2026 came in at -$11.3 million, down 71.22% year-over-year; the trailing twelve-month figure through Mar 2026 was -$883000.0 (down 115.1% YoY), and the FY2025 annual result was $3.8 million, down 68.11% from the prior year.
• Change in Cash declined to -$11.3 million in Q1 2026 per IPSC's latest filing, from $6.3 million in the prior quarter.
• Over five years, Change in Cash peaked at $69.6 million in Q1 2022 and troughed at -$27.1 million in Q4 2022.
• A 5-year average of -$259117.6 and a median of -$1.4 million in 2022 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2024 and 2025: Change in Cash jumped 221.99% in 2024, then tumbled 1183.79% in 2025.
• A 5-year view of Change in Cash shows it stood at -$27.1 million in 2022, then surged by 70.53% to -$8.0 million in 2023, then jumped by 172.42% to $5.8 million in 2024, then climbed by 9.62% to $6.3 million in 2025, then tumbled by 277.59% to -$11.3 million in 2026.
• Business Quant data shows IPSC's Change in Cash at -$11.3 million in Q1 2026, $6.3 million in Q4 2025, and -$913000.0 in Q3 2025.